Loading clinical trials...
Loading clinical trials...
Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Proof of Concept Trial Including Asymptomatic Individuals Using Baricitinib
Conditions
Interventions
Baricitinib
Locations
2
United States
Massachusetts General Hospital - ALS Site
Boston, Massachusetts, United States
Massachusetts General Hospital - AD Site
Charlestown, Massachusetts, United States
Start Date
December 5, 2022
Primary Completion Date
April 24, 2025
Completion Date
June 20, 2025
Last Updated
January 2, 2026
NCT07545473
NCT04570085
NCT07531732
NCT07290387
NCT05204017
NCT06501495
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions